Skip to main content
OpenTrials
Completed

NCT Number: NCT05113238

Oocyte Activation: Revised or Initial AGT Technique, Which is Better?! A Sibling-oocytes-split Design

This study will be conducted to compare two different Assisted Gamete treatment (AGT) with oocyte-sibling-split design control group : AGT- initial protocol for activating oocytes by culturing oocytes in calcium ionophore after injection for two rounds of 10 minutes at 37 C, 30 minutes after injection.

sample group : AGT-revised protocol oocytes will be injected by sperm previously cultured in Ca ionophore and 0.4 pL of calcium ionophore then will be cultured in calcium ionophore after injection for 10 minutes

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–40 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Royal Fertility Center

Al Mansurah, Daqahlya, 35511, Egypt

About this study

investigators performed ICSI then with one of two activation protocols added : AGT-initial or AGT-revised For the AGT initial protocol, Oocytes will be injected then will be incubated in 10 mM calcium ionophore (Sigma-Aldrich) for two rounds of 10 minutes at 37 C, 30 minutes after ICSI injection, and then will be rinsed and transferred into culture medium.

For the AGT-revised protocol, ejaculated spermatozoa will be exposed to calcium ionophore in a drop on the ICSI dish before injection. During the ICSI procedure, spermatozoa will be aspirated individually from the drop containing calcium ionophore and immobilized in a separate polyvinylpyrrolidone drop. Next, approximately 0.4 pL of calcium ionophore will be aspirated into the micropipette and will be injected into the oocyte with the spermatozoa. Post-ICSI oocytes will be then exposed to 50 mM calcium ionophore for 10 minutes at 37 C, and then will be washed and placed in culture medium.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • couples presented with an extremely poor fertilization (<10%)
  • couples with previous complete fertilization failure after undergoing ICSI cycles
  • At least 4 MII oocytes
  • Severe oligoasthinozoospermia
  • Teratozoospermia
  • testicular aspirated sperm

Exclusion criteria

  • age >40 years
  • BMI >34
  • aspirated oocytes < 4
  • Normozoospermia
  • subfertile patients

Treatment and study plan

Assisted gamete activation

Procedure

compare two different assisted gamete activation protocols to improve ICSI outcome

Primary outcomes

  1. Number of top quality day 3 embryos

    Time frame: 3 days after ICSI procedure day

    number of top quality embryos

  2. Number of Top quality day 4 embryos

    Time frame: 4 days after ICSI procedure

    number of top quality embryos

  3. Number of Top quality day 5 embryos

    Time frame: 5 days after ICSI procedure

    number of top quality embryos

Secondary outcomes

  1. chemical pregnancy rate

    Time frame: 15 days after embryo transfer procedure day

    the number of positive pregnancy cases from overall cases

Sponsors and collaborators

Lead sponsor

Royal Fertility Center, Egypt

Other

Collaborators

  • Hawaa Fertility Center

Registry information

Official study title

Oocyte Activation: Revised or Initial Activated Gamete Treatment (AGT) Technique, Which is Better?! A Sibling-oocytes-split Design and Case Series of Chemical Pregnancies

Important dates

Study start
2021
Primary completion
2021
Study completion
2021
First posted
Nov 9, 2021
Registry last updated
Sep 21, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.